James Yao - Articles and news items

Novartis logo

Novartis gains FDA approval for Afinitor®

Industry news, News / 5 May 2011 / Novartis

Novartis announced today that the FDA approved Afinitor® (everolimus) tablets for the treatment of progressive neuroendocrine tumors of pancreatic origin (PNET)…

Novartis logo

Novartis drug Afinitor® extends progression-free survival in patients with advanced pancreatic NET

Industry news, News / 9 February 2011 / Novartis

NEJM published a study that shows Afinitor® tablets plus BSC more than doubled PFS…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+